WASHINGTON (dpa-AFX) - Novavax Inc. (NVAX) said that it has filed for provisional approval of its COVID-19 vaccine to the New Zealand Medicines and Medical Devices Safety Authority (Medsafe).The
- Submission to New Zealand's Medsafe marks the first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities in New Zealand - All modules required for regulatory